As of 6 Jul 2026, Poly Medicure share price is ₹1,702.60. The stock opened at ₹1,689.90, compared to its previous close of ₹1,677.80. During today's trading session, Poly Medicure share price moved in the range of ₹1,665.90 to ₹1,712.00, with an average price of ₹1,688.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,182.00 and a high of ₹2,316.60. On the performance front, Poly Medicure share price has declined by 5.19% over the last six months and is down 25.14% on a year-on-year basis.
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,27,930.00 | 63.88 | 13.51 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 77.81 | 10.44 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.13 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.76 | 9.02 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,286.90 | 65.48 | 9.16 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,732.10 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 43.61 | 8.78 | 21.78% | 0.07 | 27.45% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,771.50 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| DR AGARWALS HEALTH CARE L | 15,099.50 | 90.50 | 7.51 | 6.58% | 0.34 | 9.75% | 62.82 | 0.00% | 0.49 | 1.25 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,669.83 | ₹1,375.80 | ₹1,115.23 | ₹923.06 |
| Other Income | ₹89.13 | ₹58.75 | ₹36.19 | ₹37.90 |
| Total Revenue | ₹1,758.96 | ₹1,434.54 | ₹1,151.42 | ₹960.97 |
| Total Expenses | ₹1,311.62 | ₹1,092.80 | ₹915.85 | ₹768.17 |
| Profit Before Tax | ₹452.52 | ₹344.27 | ₹237.49 | ₹195.24 |
| Tax | ₹113.96 | ₹86.01 | ₹58.21 | ₹48.74 |
| Profit After Tax | ₹338.56 | ₹258.26 | ₹179.28 | ₹146.51 |
| EPS - Basic | ₹34.13 | ₹26.92 | ₹18.69 | ₹15.28 |
| EPS - Diluted | ₹34.11 | ₹26.90 | ₹18.67 | ₹15.27 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹452.52 | ₹344.27 | ₹237.49 | ₹195.24 |
| Income before WC changes | ₹487.15 | ₹381.04 | ₹298.65 | ₹234.32 |
| Change in Assets | -₹158.80 | -₹53.79 | -₹70.25 | -₹100.64 |
| Change in Liabilities | ₹4.48 | ₹13.13 | ₹20.30 | ₹37.25 |
| Change in WC | -₹154.32 | -₹40.66 | -₹49.96 | -₹63.39 |
| Cash flow from Operations | ₹240.42 | ₹266.08 | ₹190.83 | ₹123.47 |
| Cash flow from Investing | -₹1,194.28 | -₹240.94 | -₹179.02 | -₹85.33 |
| Cash flow from Financing | ₹950.51 | -₹20.15 | -₹12.51 | -₹35.34 |
| Total Cash Flow | -₹3.35 | ₹4.99 | -₹0.70 | ₹2.80 |
| Cash (Start of the year) | ₹12.05 | ₹7.06 | ₹7.76 | ₹4.95 |
| Cash (End of the year) | ₹8.70 | ₹12.05 | ₹7.06 | ₹7.76 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,275.46 | ₹1,017.07 | ₹770.20 | ₹593.40 |
| Current Assets | ₹1,917.00 | ₹841.60 | ₹807.01 | ₹783.44 |
| Total Assets | ₹3,192.45 | ₹1,858.67 | ₹1,577.21 | ₹1,376.83 |
| Current Liabilities | ₹370.17 | ₹351.21 | ₹293.30 | ₹226.68 |
| Net Current Asset | ₹1,546.83 | ₹490.39 | ₹513.70 | ₹556.76 |
| Non-Current Liabilities | ₹56.63 | ₹37.40 | ₹42.28 | ₹62.68 |
| Equity Capital | ₹2,765.66 | ₹1,470.05 | ₹1,241.63 | ₹1,087.48 |
| Total Equity & Liabilities | ₹3,192.45 | ₹1,858.67 | ₹1,577.21 | ₹1,376.83 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,601.80 | ₹1,307.25 | ₹1,068.05 | ₹879.36 |
| Other Income | ₹89.77 | ₹58.18 | ₹36.29 | ₹38.73 |
| Total Revenue | ₹1,691.57 | ₹1,365.43 | ₹1,104.33 | ₹918.09 |
| Total Expenses | ₹1,248.68 | ₹1,030.53 | ₹867.51 | ₹723.37 |
| Profit Before Tax | ₹442.89 | ₹334.89 | ₹236.83 | ₹194.72 |
| Tax | ₹111.56 | ₹83.17 | ₹57.78 | ₹48.70 |
| Profit After Tax | ₹331.33 | ₹251.72 | ₹179.04 | ₹146.02 |
| EPS - Basic | ₹33.40 | ₹26.24 | ₹18.67 | ₹15.23 |
| EPS - Diluted | ₹33.39 | ₹26.22 | ₹18.65 | ₹15.22 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹442.89 | ₹334.89 | ₹236.83 | ₹194.72 |
| Income before WC changes | ₹479.25 | ₹370.72 | ₹297.00 | ₹233.32 |
| Change in Assets | -₹150.21 | -₹60.36 | -₹59.03 | -₹93.64 |
| Change in Liabilities | -₹3.38 | ₹19.48 | ₹16.70 | ₹33.45 |
| Change in WC | -₹153.59 | -₹40.87 | -₹42.33 | -₹60.19 |
| Cash flow from Operations | ₹236.65 | ₹256.10 | ₹196.83 | ₹126.26 |
| Cash flow from Investing | -₹1,191.17 | -₹237.02 | -₹189.18 | -₹88.71 |
| Cash flow from Financing | ₹952.93 | -₹17.32 | -₹7.89 | -₹39.71 |
| Total Cash Flow | -₹1.59 | ₹1.76 | -₹0.25 | -₹2.16 |
| Cash (Start of the year) | ₹2.14 | ₹0.38 | ₹0.63 | ₹2.79 |
| Cash (End of the year) | ₹0.55 | ₹2.14 | ₹0.38 | ₹0.63 |
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,280.02 | ₹1,029.57 | ₹782.49 | ₹592.97 |
| Current Assets | ₹1,860.34 | ₹791.78 | ₹755.27 | ₹740.99 |
| Total Assets | ₹3,140.36 | ₹1,821.35 | ₹1,537.76 | ₹1,333.96 |
| Current Liabilities | ₹341.80 | ₹327.51 | ₹268.95 | ₹203.27 |
| Net Current Asset | ₹1,518.54 | ₹464.27 | ₹486.32 | ₹537.72 |
| Non-Current Liabilities | ₹54.34 | ₹35.59 | ₹34.69 | ₹53.72 |
| Equity Capital | ₹2,744.22 | ₹1,458.25 | ₹1,234.12 | ₹1,076.97 |
| Total Equity & Liabilities | ₹3,140.36 | ₹1,821.35 | ₹1,537.76 | ₹1,333.96 |
Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.
Poly Medicure share price is ₹1,702.60 as on 06 Jul, 2026, 13:44 IST.
In the last 1 year, Poly Medicure delivered a return of -25.14%. The Poly Medicure share price hit a high of ₹2,316.60 and low of ₹1,182.00.
The Mutual Fund Shareholding in Poly Medicure was 8.84% at the end of Mar 2026.
The 52-week high and low of Poly Medicure share is ₹2,316.60 and ₹1,182.00 as of 06 Jul, 2026.
The market capitalisation of Poly Medicure is ₹17,028.90 Crores as on 06 Jul, 2026.
The stock symbol of Poly Medicure is POLYMED on the NSE, 531768 on the BSE, and the ISIN is INE205C01021.
Poly Medicure shares closed yesterday at ₹1,677.80 on NSE & ₹1,680.05 on BSE
To buy Poly Medicure shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
No, shares of Poly Medicure or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Poly Medicure shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
The PE and PB ratio of Poly Medicure is 53.1 and 5.48 respectively, as on 06 Jul, 2026, 13:44 IST.